TNN Citicoline Sodium
Review
Description
Product Parameter
Test Items
|
Specification
|
|
Appearance | White crystalline or crystalline powder, odorless | |
Solubility | Freely soluble in water, insoluble in ethanol, in acetone and in chloroform | |
Identification
|
Comply with the standard |
|
PH
|
6.0-7.5
|
|
Clarity and color of solution
|
Should be clear and colorless
|
|
Chlorides ≤0.05% | Ammonium salt ≤0.05% | Iron ≤0.01% |
Phosphates ≤0.1% | Loss on drying ≤6.0% | Heavy metals ≤0.0005% |
Arsenic ≤0.0001% | Bacterial endotoxins <0.3EU/mg | |
Microbial contamination | Total bacterial count≤1000cfu/g | |
Yeast & molds≤100cfu/g | ||
E.coli: not detected | ||
5'-CMP≤0.3% | ||
Other signle 1 impurities≤0.2% | ||
Other total impurities≤0.7% | ||
Methanol≤0.3% | ||
Ethanol≤0.5% | ||
Acetone≤0.5% | ||
Assay | NLT 98.0% Citicoline sodium, calculated on the anhydrous basis |
CAS No.: 33818-15-4
Other Names: CITICOLINE SODIUM SALT
MF: C14H25N4NaO11P2
EINECS No.: 251-689-1
Place of Origin: China (Mainland)
Type: Central Nervous System Agents
Grade Standard: Medicine Grade, Tech Grade
Model Number: HCS
Purity: 99%min
Product Name: Citicoline Sodium
Appearance: White Crystalline Powder
Packing & Delivery
In 20kg drum
Application
Acute craniocerebral trauma and consciousness disorder after brain surgery, hemiplegia caused by cerebral stroke can gradually restore the function of the limbs, can also be used for other central nervous system acute injury caused by functional and consciousness disorders, also used for ischemic cerebrovascular disease and vascular dementia.